Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record for the pembrolizumab and radiotherapy melanoma trial is now displayed, including its study design, eligibility criteria, outcomes, and results-related details.
    Difference
    49%
    Check dated 2026-11-08T13:17:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:09:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the inaccessible study record.
    Difference
    1%
    Check dated 2026-10-25T13:32:11.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:39:35.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:11.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study page now redirects to a 403 Forbidden error screen, indicating restricted access to the content. The error page shows the site header/footer but no study details.
    Difference
    18%
    Check dated 2026-09-20T20:30:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.